DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE
Clinical trials for DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE trials appear
Sign up with your email to follow new studies for DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to extend remission in elderly lymphoma patients
Disease control OngoingThis study is for people aged 75 or older who have been newly diagnosed with certain aggressive types of B-cell lymphoma. It tests whether adding an oral medication (CC-486, or oral azacitidine) to the standard reduced-dose chemotherapy regimen (R-miniCHOP) can help keep the canc…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Immunotherapy duo takes on tough lymphomas
Disease control OngoingThis phase 2 trial tests whether adding varlilumab to nivolumab helps people with aggressive B-cell lymphomas that have returned or not responded to treatment. About 54 participants will receive either nivolumab alone or nivolumab plus varlilumab. The goal is to see if the combin…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Nanochip could spot lymphoma relapse early
Knowledge-focused OngoingThis pilot study is testing a nanochip (ILN biochip) to see if it can monitor how well treatment is working and detect relapse in people with diffuse large B-cell lymphoma. About 73 patients will provide blood samples for the chip to analyze genetic markers. The goal is to find o…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC